Lovastatin induces apoptosis by inhibiting mitotic and post-mitotic events in cultured mesangial cells

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1359, Issue 1, 1997, Pages 13-24

  Ghosh, Paramita M ^a   Mott, Glen E ^a   Ghosh Choudhury, Nandini ^a   Radnik, Robert A ^a   Stapleton, Marissa L ^a   Ghidoni, John J ^a   Kreisberg, Jeffrey I ^a,b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b VA S Texas Health Care System   (United States)

Author keywords

Cytokinesis; Farnesol; Geranylgeraniol; Mesangial cell; Protein prenylation; RhoA

Indexed keywords

ACTIN; FARNESOL; GERANYLGERANIOL; MEVINOLIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE; CELL SIZE; CELL STRUCTURE; CHROMATIN; CONTROLLED STUDY; DNA SYNTHESIS; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; RAT;

ACTINS; ANIMALS; APOPTOSIS; BROMODEOXYURIDINE; CELL COUNT; CELL DIVISION; CELL MOVEMENT; CELL SIZE; CELLS, CULTURED; DITERPENES; FARNESOL; GLOMERULAR MESANGIUM; GTP-BINDING PROTEINS; LOVASTATIN; MICROSCOPY, ELECTRON; MICROSCOPY, VIDEO; MITOSIS; PROTEIN ISOPRENYLATION; RATS; RHOA GTP-BINDING PROTEIN;

ANIMALIA;

EID: 0030700682     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4889(97)00091-8     Document Type: Article

References (38)

1. Fenton R.G., Kung H.-F., Longo D.L., Smith M.R. Regulation of intracellular actin polymerization by prenylated cellular proteins. J. Cell Biol. 117:1992;347-356.
2. O'Donnell M.P., Kasiske B.L., Kim Y., Atluru D., Keane W.F. Lovastatin inhibits proliferation of rat mesangial cells. J. Clin. Invest. 91:1993;83-87.
3. Jones K.D., Couldwell W.T., Hinton D.R., Su Y., He S., Anker L., Law R.E. Lovastatin induces growth inhibition and apoptosis in human malignant glioma cells. Biochem. Biophys. Res. Commun. 205:1994;1681-1687.
4. Goldstein J.L., Brown M.S. Regulation of the mevalonate pathway. Nature. 343:1990;425-430.
5. Grünler J., Ericsson J., Dallner G. Branch-point reactions in the biosynthesis of cholesterol, dolichol, ubiquinone and prenylated proteins. Biochim. Biophys. Acta. 1212:1994;259-277.
6. Larochelle D.A., Vithalani K.K., DeLozanne A. A novel member of the rho family of small GTP-binding proteins is specifically required for cytokinesis. J. Cell Biol. 133:1996;1321-1329.
7. Takaishi K., Kikuchi A., Kuroda S., Kotani K., Sasaki T., Takai Y. Involvement of rho p21 and its inhibitory GDP/GTP exchange protein (rho GDI) in cell motility. Mol. Cell Biol. 13:1993;72-79.
8. Hotchin N.A., Hall A. The assembly of integrin adhesion complexes requires both extracellular matrix and intracellular rho/rac GTPases. J. Cell Biol. 131:1995;1857-1865.
9. Hall A. Ras-related proteins. Curr. Opin. Cell Biol. 5:1993;265-268.
10. Armstrong S.A., Hannah V.C., Goldstein J.L., Brown M.S. CAAX geranylgeranyl transferase transfers farnesyl as efficiently as geranylgeranyl to RhoB. J. Biol. Chem. 270:1995;7864-7868.
11. Seabra M.C., Reiss Y., Casey P.J., Brown M.S., Goldstein J.L. Protein farnesyltransferase and geranylgeranyltransferase share a common α-subunit. Cell. 65:1991;429-434.
12. rho proteins. J. Biol. Chem. 267:1992;20033-20038.
13. Hori Y., Kikuchi A., Isomura M., Katayama M., Miura Y., Fujioka H., Kaibuchi K., Takai Y. Post-translational modifications of the C-terminal region of the Rho protein are important for its interaction with membranes and the stimulatory and inhibitory GDP/GTP exchange proteins. Oncogene. 6:1991;515-522.
14. O'Donnell M.P., Kasiske B.L., Massy Z.A., Guijarro C., Swan S.K., Keane W.F. Isoprenoids and ras: potential role in chronic rejection. Kidney Int. 48:1995;S29-S33.
15. Regazzi R., Kikuchi A., Takai Y., Wollheim C.B. The small GTP-binding proteins in the cytosol of insulin-secreting cells are complexed to GDP dissociation inhibitor proteins. J. Biol. Chem. 267:1992;17512-17519.
16. Isomura M., Kaibuchi K., Yamamoto T., Kawamura S., Katayama M., Takai Y. Partial purification and characterization of GDP dissociation stimulator (GDS) for the rho proteins from bovine brain cytosol. Biochem. Biophys. Res. Commun. 169:1990;652-659.
17. Takai Y., Sasaki T., Tanaka K., Nakanishi H. Rho as a regulator of the cytoskeleton. TIBS. 20:1995;227-231.
18. Lang P., Gesbert F., Delespine-Carmagnat M., Stancou R., Pouchelet M., Bertoglio J. Protein kinase A phosphorylation of RhoA mediates the morphological and functional effects of cyclic AMP in cytotoxic lymphocytes. EMBO J. 15:1996;510-519.
19. Nobes C.D., Hall A. Rho, Rac and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia and filopodia. Cell. 81:1995;53-62.
20. Jakobisiak M., Bruno S., Skierski J.S., Darzynkiewicz Z. Cell cycle specific effects of lovastatin. Proc. Natl. Acad. Sci. USA. 88:1991;3628-3632.
21. Keyomarsi K., Sandoral L., Band V., Pardee A.B. Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin. Cancer Res. 51:1991;3602-3609.
22. Chrzanowska-Wodnicka M., Burridge K. Rho-stimulated contractility drives the formation of stress fibers and focal adhesions. J. Cell Biol. 133:1996;1403-1415.
23. Takaishi K., Sasaki T., Kameyama T., Tsukita S., Tsukita S., Takai Y. Translocation of activated rho from the cytoplasm to membrane ruffling area, cell-cell adhesion sites and cleavage furrows. Oncogene. 11:1995;39-48.
24. Frisch S.M., Vuori K., Ruoslahti E., Chan-Hui P.-Y. Control of adhesion dependent cell survival by focal adhesion kinase. J. Cell Biol. 134:1996;793-799.
25. Kita T., Brown M.S., Goldstein J.L. Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase. J. Clin. Invest. 66:1980;1094-1100.
26. De Caprio J., Yun J., Javitt N.B. Bile acid and sterol solubilization in 2-hydroxypropyl-β-cyclodextrin. J. Lipid Res. 33:1992;441-443.
27. Kreisberg J.I., Venkatachalam M.A., Radnick R.A., Patel P.Y. Role of myosin light-chain phosphorylation and microtubules in stress fiber morphology in cultured mesangial cells. Am. J. Physiol. 249:1985;F227-F235.
28. Bordier C. Phase separation of integral membrane proteins in Triton X-114 solution. J. Biol. Chem. 256:1981;1604-1607.
29. Kerr J.F.R., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer. 26:1972;239-257.
30. Oberhammer F., Wilson J.W., Dive C., Morris I.D., Hickman J.A., Wakeling A.E., Walker P.R., Sikorska M. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J. 12:1993;3679-3684.
31. Maltese W.A. Induction of differentiation in murine neuroblastoma cells by mevinolin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Biochem. Biophys. Res. Commun. 120:1984;454-460.
32. Addeo R., Altucci L., Battista T., Bonapace I.M., Cancerni M., Cicatiello L., Germano D., Pacilio C., Salzano S., Bresciani F., Weisz A. Stimulation of human breast cancer MCF-7 cells with estrogen prevents cell cycle arrest by HMG-CoA reductase inhibitors. Biochem. Biophys. Res. Commun. 220:1996;864-870.
33. Sumi S., Beauchamp R.D., Townsend C.M., Uchida T., Murakami M., Rajaraman S., Ishizuka J., Thompson J.C. Inhibition of pancreatic adenocarcinoma cell growth by lovastatin. Gastroenterology. 103:1992;982-989.
34. Newman A., Clutterbuck R.D., Powles R., Millar J.L. Selective inhibition of primary acute myeloid leukaemia cell growth by lovastatin. Leukemia. 8:1994;274-280.
35. Xu L., Owens L.V., Sturge G.C., Yang X., Liu E.T., Craven R.J., Cance W.G. Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells. Cell Growth Differentiation. 7:1996;413-418.
36. Barry S.T., Critchley D.R. The RhoA dependent assembly of focal adhesions in Swiss 3T3 cells is associated with increased tyrosine phosphorylation and the recruitment of both pp125 FAK and protein kinase C-∂ to focal adhesions. J. Cell Sci. 107:1994;2033-2045.
37. McGuire T.F., Qian Y., Vogt A., Hamilton A.D., Sebti S.M. Platelet-derived growth factor receptor tyrosine phosphorylation requires protein geranylgeranylation but not farnesylation. J. Biol. Chem. 271:1996;27402-27407.
38. Vogt A., Qian Y., McGuire T.F., Hamilton A.D., Sebti S.M. Protein geranylgeranylation, not farnesylation, is required for the G1 to S phase transition in mouse fibroblasts. Oncogene. 13:1996;1991-1999.